
Novel Therapies for the “Forgotten Valve”: Advances In Tricuspid Valve Treatment
For years, the tricuspid valve has been referred to as the “forgotten valve,” often overshadowed by more well-known heart valves such as the mitral and aortic valves. Traditionally, tricuspid valve disease has required surgical intervention, and due to the complex patient population—typically with multiple comorbidities—many surgeons have been reluctant to treat it aggressively. However, recent advancements in both percutaneous and surgical therapies have transformed this landscape.

TMH Cardiologists Lead Development of Groundbreaking Mitral Valve Procedure
Cardiologists at Tallahassee Memorial HealthCare (TMH) have participated in trials demonstrating promising outcomes with a novel approach for treating patients with functional mitral regurgitation, a condition with few therapeutic options.

Cardiothoracic Surgery Director Shares Vision For Program
Tallahassee Memorial HealthCare (TMH) is expanding its cardiothoracic surgical program under the leadership of Alfredo R. Ramirez, MD, a highly experienced cardiothoracic surgeon who joined TMH in 2024.
Send Your Referrals Electronically
Tallahassee Memorial HealthCare and TMH Physician Partners, Services by Southern Medical Group are now using Epic for electronic medical records and referrals. Epic allows TMH to collaborate more closely with private practitioners in the community through EpicCare Link, an interface that gives practices the ability to see patients’ charts, place orders and communicate electronically with TMH providers.
With EpicCare Link: You can place electronic order for referrals, labs and imaging at TMH. You may view patients’ charts, including up-to-date results on pre and post operative lab orders. Electronic case requests are ready to schedule as soon as they are placed.
Sign up for EpicCare Link by emailing us at carelink@TMH.ORG.

Revolutionizing Clot Removal for High-Risk Patients
The AngioVac (AngioDynamics) system has emerged as the first aspiration thrombectomy device capable of removing significant intravascular material—such as thrombus, vegetation and tumors—without the need for thrombolysis or open surgery. This innovative technology has been successfully used to manage acute and subacute iliocaval thrombosis, catheter-related central venous thrombus, atrial tumors/thrombus, valve vegetations, and submassive and massive pulmonary emboli.

AFib Patients Benefit From Comprehensive Approach at TMH
Patients with atrial fibrillation (AFib) benefit from a multidisciplinary approach to care that begins at diagnosis and continues through treatment. Tallahassee Memorial HealthCare (TMH) is a regional leader in incorporating state-of-the-art treatment technologies into clinical practice.

Lead Implantation and Extraction Initiatives at TMH Boost Survival, Patient Safety
The lead management and extraction program at Tallahassee Memorial HealthCare (TMH) takes a comprehensive approach to patient safety, aimed at minimizing potential complications and, ultimately, saving lives.

TMH Offers Comprehensive Care for Patients With Complex Vascular Needs
Patients requiring complex vascular surgeries now have access to a dedicated, multispecialty team at Tallahassee Memorial HealthCare (TMH). This team, part of TMH Physician Partners, Services by Southern Medical Group, is located on the main campus and includes internal medicine physicians, cardiologists, cardiothoracic surgeons and, most recently, highly accomplished vascular surgeons.

Saving Limbs, Saving Lives: The Critical Limb Ischemia Program at TMH
At TMH, patients have access to the comprehensive, multidisciplinary expertise of the cardiovascular specialists from TMH Physician Partners, Services by Southern Medical Group, including interventional cardiologists and vascular surgeons. They also benefit from two state-of-the-art interventional cardiac catheterization laboratories designed specifically to treat patients with CLI.

TMH Leads Use of Novel Approaches for Left Atrial Appendage Management
Tallahassee Memorial HealthCare (TMH) offers unique and innovative approaches to left atrial appendage (LAA) management for patients with arrhythmia, including atrial fibrillation (AFib)—the most common type of arrhythmia, often associated with significant complications.1 The LAA is a small, ear-shaped pouch attached to the left atrium of the heart where blood clots can form in patients with AFib. “About 90% of strokes caused by nonvalvular AFib originate in the LAA,” said Venkata Bavikati, MD, an electrophysiologist with TMH Physician Partners, Services by Southern Medical Group. “Most patients are treated with anticoagulants or blood thinners, but some cannot tolerate or safely take these medications.”

New Ablation Technique Improves Safety and Outcomes for AFib Patients
Pulsed-field ablation (PFA) is a novel energy source for ablation of atrial fibrillation (AFib) and is a virtually non-thermal mode of delivering ablation lesions. This has significantly improved the safety profile of AFib ablation and reduced the procedure time. TMH was one of the first centers to employ this technology following FDA approval in the spring of 2024.

TMH at Forefront of Emerging Field Of Cardio-Oncology
The latest advancements in chemotherapeutic regimens, including targeted therapies and immunotherapy drugs, have revolutionized cancer treatment, achieving outcomes that are “almost curative” for various malignancies. However, many of these therapies also carry significant cardiotoxic risks, which increase patients’ likelihood of developing end-stage heart failure and other serious cardiovascular complications.
Heart and Vascular Care
Offering the most advanced programs in the Southeast
Our cardiovascular physicians perform more complex procedures and clinical research than any other program in our region. From structural heart care to heart, lung and chest surgery and everything in between, there’s no need to go anywhere else for advanced cardiovascular care.